Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism

Impact of Association of Individual and Group Therapeutic Education Sessions on the Acquisition of Safety Skills by Patients With Chronic Inflammatory Rheumatism (CIR) Treated With Subcutaneous Biotherapy, Compared to Individual Therapeutic Education Sessions Alone

The hypothesis is that group interaction associated with individual interviews intensify the acquisition of safety skills compared to individual interviews alone in patients with CIR treated by subcutaneous biotherapies.

Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signature of consent, patients will be randomized by 1: 1 randomization (centralized randomization by statistician into 2 groups at M0) :

1. Experimental group (individual and group therapeutic education )

   • M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management".
   • M3 (group with 3 to 10 patients) Intensification Biotherapy Education: Workshops : "Subcutaneous injection education" and "biotherapy management".
   • M6 (individual presential or by phone) Assessment of security skills and questionnaires.
   • M12 (individual presential or by phone) Assessment of security skills and questionnaires.

2. Control group (individual therapeutic education alone ) :

   • M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management".
   • M3 (individual) Intensification Biotherapy Education: "Subcutaneous injection education" and "biotherapy management".
   • M6 (individual présential or by phone) Assessment of security skills and questionnaires.
   • M12 (individual présential or by phone) Assessment of security skills and questionnaires. Group session proposed.

Inclusion Criteria:

• Patient age > 18 years old with RA (ACR/EULAR criteria) or SA (ASAS criteria) initiating a first subcutaneous biotherapy.
• Patient able to complete a questionnaire
• Patient giving informed consent.
• Patient covered by social security

Exclusion Criteria:

• - Patient with disorder of higher mental function or psychiatric disorders.
• Patient previously treated by intravenous biotherapy.
• Protected populations: pregnant women, breastfeeding women, tutorship, trusteeship, deprived of liberty, safeguard of justice.